PUBLISHER: The Business Research Company | PRODUCT CODE: 1948268
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948268
A spirometer is a device utilized to evaluate lung function by measuring the volume of air a person inhales and exhales, as well as the duration of exhalation. It serves as a diagnostic tool for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other respiratory conditions affecting breathing.
Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.
Tariffs are impacting the spirometer market by increasing costs of imported sensors, electronic components, precision flow meters, and embedded software systems used across handheld, tabletop, and desktop devices. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are increasing procurement costs and slowing replacement cycles. However, they are also encouraging localized manufacturing, regional sourcing of components, and development of cost-optimized digital spirometry solutions.
The spirometer market research report is one of a series of new reports from The Business Research Company that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The spirometer market size has grown strongly in recent years. It will grow from $1.27 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising prevalence of respiratory disorders, increasing hospital-based pulmonary diagnostics, growing awareness of lung health assessment, availability of standardized spirometry guidelines, expansion of diagnostic equipment usage.
The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory monitoring, rising demand for telehealth-enabled diagnostics, growing investments in digital healthcare infrastructure, increasing focus on early disease detection, expansion of software-integrated spirometry platforms. Major trends in the forecast period include increasing adoption of digital and connected spirometers, rising integration of software-based lung function analysis, growing use of portable and handheld spirometers, expansion of remote respiratory monitoring capabilities, enhanced focus on diagnostic accuracy and standardization.
The rising prevalence of chronic respiratory diseases is anticipated to drive demand for spirometers in the coming years. Chronic respiratory diseases are long-term conditions affecting the airways and other parts of the lungs, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung disorders. These conditions are largely associated with factors such as tobacco use, air pollution, occupational hazards, and genetic susceptibility. Spirometers play a vital role in the management of chronic respiratory diseases by assessing lung function, which enables clinicians to track disease progression and evaluate treatment outcomes. The resulting data supports timely adjustments to therapy and the development of personalized treatment strategies, ultimately improving respiratory health outcomes. For example, in November 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia, respiratory conditions accounted for 7.2% of the total disease burden, 8.5% of non-fatal health loss, and 5.8% of premature mortality in 2023. As a result, the growing burden of chronic respiratory diseases is contributing to increased demand for spirometers.
Major companies in the spirometer market are concentrating on creating innovative solutions like app-based platforms to assist users in tracking lung health and sharing data with healthcare providers. These app-based platforms enable users to monitor their lung function, receive real-time feedback, and communicate with healthcare professionals for better management of respiratory conditions. For example, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing firm, introduced AsthmaGo. AsthmaGo is an advanced app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor their lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their conditions effectively and share health data with caregivers for personalized care.
In January 2023, CAIRE Inc., a United States-based manufacturer of oxygen therapy and on-site oxygen generation systems, acquired MGC Diagnostics Holdings, Inc. for an undisclosed sum. This acquisition was intended to broaden CAIRE's clinical healthcare offerings by incorporating advanced diagnostic technologies, thereby supporting more comprehensive patient care across the full spectrum of pulmonary disease progression. MGC Diagnostics Holdings, Inc. is a United States-based provider of cardiorespiratory diagnostic solutions, offering products such as spirometers, body plethysmographs, cardiopulmonary exercise testing systems, flow sensors, gas analyzers, and associated consumables.
Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.
North America was the largest region in the spirometer market share in 2025. The regions covered in the spirometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Spirometer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses spirometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for spirometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spirometer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.